Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
BMC Infectious Diseases|August 22, 2025
Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3 clinical trialsCissy M Kityo, Samir K Gupta, Princy N Kumar, et al.
Sexually Transmitted Diseases|October 27, 2023
The Tenacious Treponema: A Retrospective Examination of Syphilis Treatment Disparities in Washington, DCKaitlin Liroff, Seble G Kassaye, Amanda B Spence, et al.
The Neurohospitalist|December 24, 2021
Healthcare Worker With Large Vessel Acute Ischemic Stroke Likely Related to Mild SARS-CoV-2 InfectionCarlos Castillo-Pinto, Guillaume Lamotte, Amit Mehta, et al.
AIDS and Behavior|October 23, 2023
Mixed Methods Analysis of Telehealth Experience, Satisfaction, and Quality of Care During the COVID Pandemic Among Persons with HIV in Washington, DCShannon K Barth, Kacie J Saulters, Gayle P Balba, et al.
Open Forum Infectious Diseases|July 17, 2025
Efficacy and Safety of Doravirine-based Regimens by Sex and Race: Long-term Results From Three Phase 3 Clinical TrialsSharon L Walmsley, Princy N Kumar, Chloe Orkin, et al.
AIDS (London, England)|June 23, 2009
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatmentKimberly Y Smith, Parul Patel, Derek Fine, et al.
Open Forum Infectious Diseases|October 11, 2021
Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV CohortsAnne K Monroe, Matthew E Levy, Alan E Greenberg, et al.
Plos One|June 3, 2022
Cingulate transcranial direct current stimulation in adults with HIVXiong Jiang, Sophia Dahmani, Margarita Bronshteyn, et al.
Plos One|June 6, 2024
Correction: Cingulate transcranial direct current stimulation in adults with HIVXiong Jiang, Sophia Dahmani, Margarita Bronshteyn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for RecurrenceDale N Gerding, Ciaran P Kelly, Galia Rahav, et al.
Pageof 5